AFOS
ARS Focused Opportunities Strategy ETF
ARS Focused Opportunities Strategy ETF seeks to provide long-term capital appreciation by investing primarily in equity securities of companies that exhibit growth potential, while employing a focused investment approach.
US
EQUITY
Active
MANAGEMENT STYLE
$ 283.4 M
ASSETS UNDER MGMT
45 bp
EXPENSES
Fund Basics
| Inception date | Jun 25, 2025 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| CASH & OTHER | 7.9 % |
| MARATHON PETROLEUM | 5.8 % |
| LAM RESEARCH CORP | 4.7 % |
| ALPHABET INC. CLASS A | 4.7 % |
| NVIDIA CORP | 4.2 % |
| WESTERN DIGITAL CORP | 4.2 % |
| GE VERONA | 4.0 % |
| MICRON TECHNOLOGY INC | 3.8 % |
| ASCENDIS PHARMA A/S | 3.6 % |
| BLACKSTONE GROUP LP/THE | 3.5 % |
Constituent Breakdown
| Number of holdings | 30 |
| Herfindahl-Hirschman Index | 375 |
| Wgt avg mkt cap (mns) | $812,858 |
| Large cap (>$10bn) | 84.3% |
| Mid cap ($2-10bn) | 7.8% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 92.2% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
| UNITED STATES | 81.8 % | |
| IRELAND | 4.7 % | |
| DENMARK | 3.6 % | |
| CANADA | 2.1 % |
Historical Performance
Standardized Performance (as of 06/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 35.7% | 82.2% | -- | -- | -- | -- | -- | 83.1% |
| Dividend Yield | 0.0% | 0.5% | -- | -- | -- | -- | -- | 0.5% |
| Total Returns | 35.7% | 82.8% | -- | -- | -- | -- | -- | 83.6% | Ann. Volatility | 26.2% | 21.8% | -- | -- | -- | -- | -- | 21.7% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.46 | 69% |
| MSCI EAFE | 1.04 | 55% |
| MSCI Emg Mkts | 0.79 | 68% |
Liquidity Measures
| Avg. volume (000) | 9 |
| ADV traded (mns) | $0 |
| Turnover | 0.1% |
| Avg. Bid/Ask (% of price) | 0.14% |
Technical Indicators
| 30d moving avg. (EMA) | $44.66 |
| Relative strength (RSI) | 50 |
| MACD/Signal | -0.08/0.19 |
| Bollinger Bands (Upper/Lower) | $46.99/$43.48 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. AFOS |
Expenses vs. AFOS |
ALTAR Score™ vs. AFOS |
|---|---|---|---|---|
| SQS | Sapient Quality Select ETF | 34.5% | +35 bp | -0.1% |
| FSST | Fidelity Sustainable U.S. Equity ETF | 33.7% | +14 bp | +2.0% |
| RAYD | Rayliant Quantitative Developed Market Equity ETF | 30.5% | +35 bp | +1.6% |
| SGLC | SGI U.S. Large Cap Core ETF | 29.9% | +40 bp | +1.6% |
| CAML | Congress Large Cap Growth ETF | 28.7% | +21 bp | +0.6% |
| BGRO | iShares Large Cap Growth Active ETF | 28.1% | +10 bp | -0.2% |
| QGRW | WisdomTree U.S. Quality Growth Fund | 28.0% | -17 bp | +1.2% |
| FFLC | Fidelity Fundamental Large Cap Core ETF | 27.8% | -7 bp | +1.8% |
| GK | AdvisorShares Gerber Kawasaki ETF | 27.3% | +30 bp | -0.5% |
| DARP | Grizzle Growth ETF | 26.9% | +30 bp | -0.1% |
Risk and Returns: AFOS vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 7/20/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
2.8%
ALTAR SCORE™
11st
PERCENTILE
AVOID
ETFRC RATING
There are 1,401 funds in the US Equity category with an average
ALTAR Score™ of 5.4% and a standard deviation
of 2.1%. AFOS's ALTAR Score™ is approximately -1.2 standard
deviations above the category average. This places AFOS in the 11st percentile
among funds in the category.
Sell-Side Consensus
$48.92
PRICE TARGET
+12.0%
UPSIDE